Cite
PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer.
MLA
Serra, V., et al. “PI3K Inhibition Results in Enhanced HER Signaling and Acquired ERK Dependency in HER2-Overexpressing Breast Cancer.” Oncogene, vol. 30, no. 22, June 2011, pp. 2547–57. EBSCOhost, https://doi.org/10.1038/onc.2010.626.
APA
Serra, V., Scaltriti, M., Prudkin, L., Eichhorn, P. J. A., Ibrahim, Y. H., Chandarlapaty, S., Markman, B., Rodriguez, O., Guzman, M., Rodriguez, S., Gili, M., Russillo, M., Parra, J. L., Singh, S., Arribas, J., Rosen, N., & Baselga, J. (2011). PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer. Oncogene, 30(22), 2547–2557. https://doi.org/10.1038/onc.2010.626
Chicago
Serra, V, M Scaltriti, L Prudkin, P J A Eichhorn, Y H Ibrahim, S Chandarlapaty, B Markman, et al. 2011. “PI3K Inhibition Results in Enhanced HER Signaling and Acquired ERK Dependency in HER2-Overexpressing Breast Cancer.” Oncogene 30 (22): 2547–57. doi:10.1038/onc.2010.626.